High Specific Activity Radionuclides (HSARNs), obtained by either proton, deuteron or alpha cyclotron irradiation, followed by selective radiochemical separation from the irradiated target in No Carrier Added (NCA) form represent a powerful analytical tool in pure and applied sciences and technologicies. One of the main applications of HSARNs concern medical radiodiagnostics and metabolic radiotherapy in the relatively novel theranostic paradigm that involves individual “dual-purpose” radionuclides or radionuclide pairs with emissions suitable for both imaging and therapy in the contest of the age-long dream of personalized medicine. We present some examples of radionuclides produced by deuteron beams irradiation, suitable for theranostics applications.
Radionuclides for theranostic applications / F. Groppi Garlandini, G. Harki, E. Sabbioni, S. Manenti - In: 106° Congresso Nazionale / [a cura di] B. Alzani, M. Bellacosa e G. Bianchi Bazzi. - [s.l] : Società Italiana di Fisica, 2020. - ISBN 9788874381234. - pp. 74-74 (( Intervento presentato al 106. convegno Congresso Nazionale SIF tenutosi a Milano nel 2020.
Radionuclides for theranostic applications
F. Groppi Garlandini
Primo
;S. ManentiUltimo
2020
Abstract
High Specific Activity Radionuclides (HSARNs), obtained by either proton, deuteron or alpha cyclotron irradiation, followed by selective radiochemical separation from the irradiated target in No Carrier Added (NCA) form represent a powerful analytical tool in pure and applied sciences and technologicies. One of the main applications of HSARNs concern medical radiodiagnostics and metabolic radiotherapy in the relatively novel theranostic paradigm that involves individual “dual-purpose” radionuclides or radionuclide pairs with emissions suitable for both imaging and therapy in the contest of the age-long dream of personalized medicine. We present some examples of radionuclides produced by deuteron beams irradiation, suitable for theranostics applications.File | Dimensione | Formato | |
---|---|---|---|
Pagine da atti_congresso_106-3_radionuclides.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
969.26 kB
Formato
Adobe PDF
|
969.26 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.